RxDoctor Payments Data

Muslima Billah

Physician Assistant · Salt Lake City, UTNPI 1124596192

Payments from drug & device makers

$2,728in general payments, 2019–2025

Across 141 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$553
  • AbbVie$520
  • Exact Sciences$282
  • Lilly USA, LLC$269
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$184
  • AstraZeneca$147
  • plus $772 from 14 others

What the payments were for

  • Food & beverage$2,56794%
  • Education$1616%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,728 in reported general payments places this provider in the 85th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide112$118,857
JardianceEmpagliflozin97$102,519
FarxigaDapagliflozin Propanediol49$54,642
JanuviaSitagliptin Phosphate52$52,306
EliquisApixaban23$27,404
MounjaroTirzepatide23$24,156
EntrestoSacubitril/Valsartan23$23,609
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$19,978
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$18,358
XareltoRivaroxaban19$17,145
LinzessLinaclotide13$13,949
JanumetSitagliptin Phos/Metformin Hcl14$13,718
TrulicityDulaglutide12$12,463
DapagliflozinDapagliflozin Propanediol16$8,629
Breo ElliptaFluticasone/Vilanterol14$7,216

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$553$118,857112 claims
Boehringer IngelheimJardiance$86$102,51997 claims
AstraZenecaFarxiga, Breztri Aerosphere$147$74,62079 claims
Lilly USA, LLCMounjaro, Trulicity$269$36,61935 claims
PfizerEliquis$44$27,40423 claims
AbbVieLinzess, Synthroid$520$15,00326 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →